Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Research ArticleTeaching Case Study

Hybrid Imaging with SPECT/CT and SPECT/MRI in Hepatic Splenosis

Mehdi Djekidel and Mark Michalski
Journal of Nuclear Medicine Technology June 2022, 50 (2) 179-181; DOI: https://doi.org/10.2967/jnmt.121.263013
Mehdi Djekidel
1Division of Nuclear Medicine, Department of Radiology, Sidra Medicine, Doha, Qatar; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Michalski
2MGH and BWH Center for Clinical Data Science, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Hepatic splenosis is a rare entity, for which indeterminate liver lesions can pose a clinical dilemma. In difficult cases, scintigraphy can be of great value, especially with novel SPECT/CT and SPECT/MRI techniques.

  • oncology
  • hepatic splenosis
  • RBC scan
  • SPECT/CT
  • SPECT/MRI
  • sulfur colloid

Splenosis commonly occurs incidentally and locates to bowel surfaces, the parietal peritoneum, the mesentery, and the diaphragm but can potentially occur anywhere in the peritoneal cavity. Patients frequently have a history of splenectomy or trauma. On the other hand, hepatic splenosis is a rare entity and may present clinically. Indeterminate liver lesions can pose a clinical dilemma and may lead to additional investigations, anxiety, follow-up imaging, and even invasive procedures. MRI usually performs extremely well. In difficult cases, scintigraphy can be of great value, especially with novel SPECT/CT and SPECT/MRI techniques. We describe the impact of hybrid imaging in the case of a 29-y-old woman with hepatic splenosis.

CASE REPORT

Our patient presented with epigastric, right-upper-quadrant abdominal pain. She had undergone splenectomy and cholecystectomy 10 y previously because of hereditary spherocytosis. A year earlier, for workup of nephrolithiasis, she had undergone abdominal CT, which demonstrated an incidental hepatic hypodensity that could not be characterized (Fig. 1A). After symptomatic management, the patient was discharged but returned twice in the subsequent weeks because of continued abdominal pain and showed mildly elevated results on liver function tests. Consequently, the patient underwent abdominal ultrasound, which demonstrated a small, hyperechoic lesion within the right lobe of the liver (Fig. 1B). The findings were confirmed by MRI, which demonstrated an indeterminate exophytic mass within segment VI of the liver (Fig. 2).

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

(A) Single-phase CT scan obtained at different hospital does not demonstrate typical arterial enhancement (arrow). (B) Ultrasound image shows hyperechoic mass (arrow). Mass would typically be hypoechoic.

FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

Axial MR images of area of lesion (arrows). (A) T1-weighted fat-saturated volumetric interpolated breath-hold examination (VIBE) sequence shows typical hypointensity. (B) Arterial-phase T1-weighted VIBE sequence shows no uptake of gadoxetate disodium (Eovist; Bayer). (C) T2-weighted sequence shows typical hyperintensity. (D) Portal venous–phase T1-weighted VIBE sequence shows no gadoxetate disodium uptake.

After developing fevers and malaise and experiencing continued pain, the patient was admitted to the hospital, and her blood work showed atypical lymphocytes, elevated levels of lactate dehydrogenase and uric acid, and Epstein–Barr virus serologies consistent with acute mononucleosis. A biopsy of the liver lesion yielded islands of mature red blood cells and hematopoietic tissue but no hepatic tissue. Pathologic examination could not yield a definitive diagnosis.

18F-FDG PET/CT was then performed to evaluate for a possible malignancy. The scan revealed extensive metabolically active lymphadenopathy throughout the body. A pertinent finding is that the hepatic mass was not metabolically active, as seen in Figure 3. However, this finding was not sufficient, as some cancers may not be 18F-FDG–avid.

FIGURE 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3.

18F-FDG PET/CT images of lesion and lymphadenopathy (arrows). (A) Axial (left) and coronal (right) images show liver lesion exhibiting glucose metabolic activity similar to that of surrounding normal parenchyma. (B) Coronal (bottom left and right) images show widespread 18F-FDG–avid lymphadenopathy.

Biopsy of the left axillary lymph node biopsy was performed and found reactive lymphoid hyperplasia positive for Epstein–Barr virus. Infectious mononucleosis was established; however, the nature of the hepatic lesion remained unclear even after a biopsy. Further investigations were sought.

Because hematopoietic tissue was found in the hepatic lesion biopsy sample, a 99mTc-radiolabeled heat-damaged red blood cell SPECT/CT scan was obtained to evaluate for hepatic splenosis. This scan showed focal uptake correlating with the mass seen on the MRI (confirming hepatic splenosis) and a smaller focus of uptake in the left upper quadrant of the abdomen (splenule), shown in Figure 4. The patient was advised that her abdominal pain was likely related to inflammation of the ectopic splenic tissue and would improve with resolution of her infectious mononucleosis. She has done well.

FIGURE 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 4.

(A and B) 99mTc-labeled heat-damaged red blood cell images show increased uptake in hepatic (A) and left flank (B) splenule. (C and D) Coronal T1-weighted MR (C) and SPECT/MR (D) images show intrahepatic splenosis in unusual location (arrows).

DISCUSSION

Even with a relevant clinical history (splenectomy, trauma), hepatic splenosis can be challenging to diagnose and can be confused with focal nodular hyperplasia, adenoma, hepatocellular carcinoma, or metastases (1–4). MRI is the modality of choice for evaluating liver lesions. However, in clinical practice, the findings may not always be straightforward.

A review of the literature showed that about 75% of reported cases of hepatic splenosis were in men and that 95% of reported cases had a history of splenectomy. Only about 37% had no risk factors, and about 60% either had risk factors for hepatocellular carcinoma or had a preexisting malignancy.

The blood supply of splenules is derived from local arteries at implantation sites (1). Even though 99mTc-sulfur colloid or 99mTc-labeled heat-damaged red blood cells efficiently target ectopic splenic tissue (5,6) and clinch the diagnosis, invasive diagnostic measures are still performed in more than 50% of cases. About 79% of reported cases used a biopsy, fine-needle aspiration, or surgery to fully diagnose the hepatic lesion. It is surprising that only 21% underwent scintigraphy.

Coregistration of datasets from SPECT/CT or SPECT/MRI and 99mTc-labeled heat-damaged red blood cells is the best test to evaluate for splenosis or accessory spleens. Sulfur colloid, because of its normal liver biodistribution, would be a second choice. The sensitivity, specificity, and accuracy of these studies have improved. Prior reported concerns about the detectability of small lesions, or proximity to major vascular structures and the remaining spleen, are no longer applicable. As in our case, several tests were performed, whereas scintigraphy would have completed the work-up early. These techniques should be used more frequently to decrease complications, the financial burden, and anxiety related to costly follow-up imaging and invasive procedures.

CONCLUSION

In difficult cases of hepatic splenosis, scintigraphy can be of great value, especially with novel SPECT/CT and SPECT/MRI techniques.

DISCLOSURE

No potential conflict of interest relevant to this article was reported.

Footnotes

  • Published online Dec. 6, 2021.

REFERENCES

  1. 1.↵
    1. Lee JB,
    2. Ryu KW,
    3. Song TJ,
    4. et al
    . Hepatic splenosis diagnosed as hepatocellular carcinoma: report of a case. Surg Today. 2002;32:180–182.
    OpenUrlCrossRefPubMed
  2. 2.
    1. Choi GH,
    2. Ju MK,
    3. Kim JY,
    4. et al
    . Hepatic splenosis preoperatively diagnosed as hepatocellular carcinoma in a patient with chronic hepatitis B: a case report. J Korean Med Sci. 2008;23:336–341.
    OpenUrlPubMed
  3. 3.
    1. Yoshimitsu K,
    2. Aibe H,
    3. Nobe T,
    4. et al
    . Intrahepatic splenosis mimicking a liver tumor. Abdom Imaging. 1993;18:156–158.
    OpenUrlPubMed
  4. 4.↵
    1. Gruen DR,
    2. Gollub MJ
    . Intrahepatic splenosis mimicking hepatic adenoma. AJR. 1997;168:725–726.
    OpenUrlPubMed
  5. 5.↵
    1. Foroudi F,
    2. Ahern V,
    3. Peduto A
    . Splenosis mimicking metastases from breast carcinoma. Clin Oncol (R Coll Radiol). 1999;11:190–192.
    OpenUrlPubMed
  6. 6.↵
    1. Lu HC,
    2. Su CW,
    3. Lu CL,
    4. Chang CP,
    5. Lin HC
    . Hepatic splenosis diagnosed by spleen scintigraphy. Am J Gastroenterol. 2008;103:1842–1844.
    OpenUrlPubMed
  • Received for publication August 6, 2021.
  • Revision received October 25, 2021.
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 50 (2)
Journal of Nuclear Medicine Technology
Vol. 50, Issue 2
June 1, 2022
  • Table of Contents
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Hybrid Imaging with SPECT/CT and SPECT/MRI in Hepatic Splenosis
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Hybrid Imaging with SPECT/CT and SPECT/MRI in Hepatic Splenosis
Mehdi Djekidel, Mark Michalski
Journal of Nuclear Medicine Technology Jun 2022, 50 (2) 179-181; DOI: 10.2967/jnmt.121.263013

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Hybrid Imaging with SPECT/CT and SPECT/MRI in Hepatic Splenosis
Mehdi Djekidel, Mark Michalski
Journal of Nuclear Medicine Technology Jun 2022, 50 (2) 179-181; DOI: 10.2967/jnmt.121.263013
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • CASE REPORT
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Cervical Ganglioneuroblastoma Diagnosed by 68Ga-DOTATOC PET/CT in a Child with Opsoclonus Myoclonus Syndrome
  • Utility of 18F-FDG PET/CT in Assessment of Disease Extent and Response to Treatment in Xanthoma Disseminatum
  • The Role of [99mTc]Tc-Sestamibi in Functional Imaging of the Iodine-Loaded Thyroid Gland
Show more Teaching Case Study

Similar Articles

Keywords

  • oncology
  • hepatic splenosis
  • RBC scan
  • SPECT/CT
  • SPECT/MRI
  • sulfur colloid
SNMMI

© 2025 SNMMI

Powered by HighWire